VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
AEG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
AEGAegon Ltd.
$8.45$12.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAEGFinancials

Aegon Ltd. (AEG) Income Statement

30Y historyFree accessUpdated daily

Revenue growth is erratic, with a 106.2% surge in 2025Q2 followed by a 48.3% decline in 2024Q2, but the latest 2026Q2 quarter shows a return to underwriting profitability with a 91.2% combined ratio.

Income StatementBalance SheetCash FlowRatios

AEG Income Statement

Annual statement

AEG Income Statement

Aegon Ltd. (AEG) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue49.05B26.86B19.52B12.98B-21.64B46.5B40.65B61.14B14.55B53.08B49.6B31.45B43.93B45.02B42.98B31.79B49.18B46.41B7.53B45.58B49.31B45.51B28.51B28.43B31.14B31.89B30.75B22.37B16.25B14.21B11.43B
Revenue Growth %287.17%37.63%50.4%159.96%-146.54%14.39%-33.5%320.15%-72.59%7.01%57.75%-28.42%-2.43%4.74%35.23%-35.37%5.97%516.65%-83.49%-7.57%8.35%59.61%0.3%-8.72%-2.35%3.71%37.46%37.7%14.37%24.29%19.73%
Medical Costs & Claims4.66B21.2B017.69B-24.67B36.5B0003.29B3.4B2.63B3.57B2.95B3.79B0000000000000000
Medical Cost Ratio %9.49%78.9%0%136.28%113.98%78.49%0%0%0%6.2%6.84%8.35%8.13%6.55%8.81%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Gross Profit44.4B5.67B19.52B2.37B14.29B46.5B40.65B61.14B14.55B49.79B46.21B28.82B40.36B42.07B39.2B31.79B49.18B46.41B7.53B45.58B49.31B45.51B28.51B28.43B31.14B31.89B30.75B22.37B16.25B14.21B11.43B
Gross Margin %90.51%21.1%100%18.25%-66.01%100%100%100%100%93.8%93.16%91.65%91.87%93.45%91.19%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %--70.96%724.28%-83.43%-69.28%14.39%-33.5%320.15%-70.78%7.75%60.34%-28.59%-4.08%7.34%23.32%-35.37%5.97%516.65%-83.49%-7.57%8.35%59.61%0.3%-8.72%-2.35%3.71%37.46%37.7%14.37%24.29%19.73%
Operating Expenses39.42B1.34B18.86B2.76B2.2B4.89B2.88B-59.81B-13.29B-46.63B-45.41B-29.34B-38.99B-41.12B-37.32B-30.38B-47.31B-46.9B-8.61B-48.37B-45.59B-41.54B-25.47B-25.64B-28.57B-27.79B-27.07B-19.43B-14B-12.18B-9.85B
OpEx / Revenue %80.36%4.99%96.63%21.25%-10.15%10.51%7.08%-97.83%-91.36%-87.84%-91.54%-93.29%-88.76%-91.34%-86.82%-95.58%-96.19%-101.05%-114.42%-106.12%-92.46%-91.28%-89.31%-90.18%-91.72%-87.13%-88.02%-86.86%-86.19%-85.7%-86.19%
Depreciation & Amortization-344.29M-160.41M-31M34M169M1.17B722M850M1.02B148M273M1.52B936M1.18B1.3B1.69B1.64B1.72B1.69B1.45B1.92B1.48B1.74B1.84B1.95B1.5B1.34B939M771.52M657.05M409.74M
Combined Ratio %89.85%83.89%96.63%157.54%103.83%88.99%7.08%-97.83%-91.36%-81.65%-84.69%-84.94%-80.63%-84.8%-78.01%-95.58%-96.19%-101.05%-114.42%-106.12%-92.46%-91.28%-89.31%-90.18%-91.72%-87.13%-88.02%-86.86%-86.19%-85.7%-86.19%
Operating Income4.97B4.33B657M12.37B834M43.7B37.78B1.33B1.26B3.16B804M-515M1.37B950M1.88B1.4B1.87B-487M-1.08B-2.79B3.72B3.97B3.05B2.79B2.58B4.11B3.68B2.94B2.24B2.03B1.58B
Operating Margin %10.12%16.11%3.37%95.35%-3.85%93.97%92.92%2.17%8.64%5.96%1.62%-1.64%3.11%2.11%4.37%4.42%3.81%-1.05%-14.42%-6.12%7.54%8.72%10.69%9.82%8.28%12.87%11.98%13.14%13.81%14.3%13.81%
Operating Income Growth %-558.9%-94.69%1383.69%-98.09%15.68%2748.87%5.49%-60.27%293.53%256.12%-137.65%44%-49.41%33.76%-25.04%484.6%55.12%61.11%-175%-6.25%30.23%9.13%8.26%-37.17%11.46%25.27%31.02%10.45%28.66%11.35%
EBITDA4.62B4.17B626M12.41B1B44.87B38.5B2.18B2.27B3.31B1.08B1B2.3B2.13B3.18B3.09B3.51B1.23B606M-1.34B5.64B5.45B4.78B4.64B4.53B5.61B5.03B3.88B3.02B2.69B1.99B
EBITDA Margin %9.42%15.52%3.21%95.61%-4.63%96.48%94.7%3.56%15.62%6.24%2.17%3.19%5.24%4.74%7.39%9.73%7.14%2.65%8.05%-2.95%11.43%11.97%16.77%16.31%14.54%17.58%16.35%17.34%18.56%18.92%17.4%
Interest Expense483.57M323.7M6M7M7M246M405M513M507M435M347M412M371M355M467M491M426M412M526M474M362M373M664M645M730M862M796M759M698.29M744.2M639.04M
Non-Operating Income2.57B3.28B-9M384M-5M-250M00-1.25B-2.97B584M1.83B542M173M121M593M440M-435M-550M-6M0-266M218M954M0048M-2.94B-2.37B-722.59M-619.26M
Pretax Income2.45B1.04B660M-391M827M1.16B-957M1.46B751M2.39B805M-514M1.45B971M1.9B916M1.91B-464M-1.06B3.08B3.39B3.62B2.17B2.15B1.85B3.24B2.89B2.18B7.57B6.71B5.21B
Pretax Margin %4.99%3.89%3.38%-3.01%-3.82%2.5%-2.35%2.38%5.16%4.51%1.62%-1.63%3.3%2.16%4.43%2.88%3.89%-1%-14.1%6.75%6.88%7.94%7.59%7.55%5.94%10.17%9.39%9.75%46.58%47.21%45.6%
Income Tax165.94M62.43M-16M-209M71M95M-336M218M40M32M219M-83M262M123M333M44M154M-668M21M526M601M885M-511M572M353M918M850M611M366.18M285.91M208.02M
Effective Tax Rate %6.77%5.97%-2.42%53.45%8.59%8.16%35.11%14.96%5.33%1.34%27.2%16.15%18.09%12.67%17.49%4.8%8.05%143.97%-1.98%17.09%17.73%24.48%-23.6%26.64%19.09%28.31%29.44%28.01%4.84%4.26%3.99%
Net Income2.31B977M688M-179M-570M1.98B45M1.24B710M2.36B586M-432M1.19B846M1.57B869M1.76B204M-1.08B2.55B2.79B2.73B1.66B1.79B1.55B2.4B2.07B1.57B1.18B1B732.01M
Net Margin %4.72%3.64%3.52%-1.38%2.63%4.26%0.11%2.03%4.88%4.45%1.18%-1.37%2.7%1.88%3.65%2.73%3.58%0.44%-14.38%5.6%5.66%6%5.83%6.31%4.97%7.52%6.72%7.02%7.26%7.05%6.4%
Net Income Growth %3205.09%42.01%484.36%68.6%-128.79%4300%-96.37%74.51%-69.93%302.9%235.65%-136.42%40.19%-46.11%80.67%-50.6%762.25%118.85%-142.41%-8.53%2.16%64.16%-7.25%15.9%-35.46%16.02%31.59%33.12%17.76%36.82%21.57%
EPS (Diluted)1.470.600.30-0.12-0.300.48-0.090.600.271.080.22-0.160.490.290.690.470.830.13-0.721.471.861.251.221.111.041.681.491.241.031.240.64
EPS Growth %1474.36%100%350%60%-162.5%633.33%-115%122.22%-75%390.91%237.5%-132.65%68.97%-57.97%46.81%-43.37%538.46%118.06%-148.98%-20.97%48.8%2.46%9.91%6.73%-38.1%12.75%20.16%20.39%-16.94%93.75%14.29%
EPS (Basic)-0.600.37-0.12-0.300.48-0.090.600.271.080.22-0.160.490.290.690.470.830.13-0.721.471.871.251.221.111.041.691.511.261.031.270.67
Diluted Shares Outstanding1.57B1.56B2.01B1.89B2.02B2.06B2.06B2.06B2.61B2.62B2.62B2.69B2.67B2.4B1.91B1.85B1.71B1.59B1.51B1.56B1.7B1.72B1.65B1.61B1.49B1.42B1.39B1.27B1.2B1.1B1.11B

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

US CRE exposure in general account

Volatile Premium Growth Masks Underlying Trend

Aegon's reported revenue growth has been highly erratic, swinging from a 106.2% surge in 2025Q2 to a 48.3% decline in 2024Q2, suggesting the top line is heavily influenced by non-recurring items or accounting reclassifications rather than consistent organic premium momentum.

The extreme volatility in quarterly revenue growth, particularly the massive swings between 2024 and 2025, indicates that the reported figures are likely distorted by the divestment of the Dutch operations and the transition to equity accounting for the aSR stake. This makes it difficult to assess the true trajectory of the core Americas and UK businesses. Investors should focus on the underlying premium growth in the Transamerica segment, which is not clearly isolated in this data, to gauge the health of the core insurance operations.

Underwriting Profitability Emerges in Latest Quarter

The 2026Q2 combined ratio of 91.2% indicates a return to underwriting profitability, a significant improvement from prior periods where such data was unavailable, suggesting the core insurance operations are generating positive technical earnings.

A combined ratio below 100% is the fundamental benchmark for insurance profitability, and the 91.2% figure for 2026Q2 implies Aegon earned an underwriting profit of approximately 8.8 cents on every dollar of premium. This is a positive development, but the lack of historical combined ratio data prevents an assessment of whether this represents a sustainable trend or a one-quarter benefit from favorable loss experience. The loss ratio of 65.5% appears manageable, but its drivers—whether from benign mortality or reserve releases—require further investigation.

Earnings Volatility Suggests Reserve Sensitivity

The stark contrast between a $6.4B operating income in 2025Q2 and a -$2.4B loss in 2024Q4, despite similar revenue scales, may indicate significant reserve adjustments or non-cash accounting impacts that materially distort the underlying earnings trend.

For a life and diversified insurer like Aegon, large swings in operating income that are not mirrored by proportional revenue changes often point to reserve releases or strengthening actions. The 2024Q4 operating loss, for instance, could reflect a one-time reserve charge related to the Dutch divestment or IFRS 17 adjustments. Conversely, the strong 2025Q2 result might be flattered by favorable prior-year reserve development. Without explicit disclosure, the quality and sustainability of reported earnings remain opaque.

Investment Income Data Unavailable for Analysis

The provided income statement data does not include a line item for investment income, which is a critical component of total earnings for a life insurer and prevents a full assessment of the company's profitability drivers.

For insurers, investment income from the general account is a primary profit center, often offsetting underwriting losses. The absence of this data in the provided table is a significant gap, as it makes it impossible to evaluate Aegon's net investment yield, its spread over liability costs, or its sensitivity to interest rate movements. This omission means the analysis of overall profitability is incomplete, as the combined ratio only captures the underwriting side of the business.

2024 Marks a Period of Structural Transformation

The 2024 fiscal year, characterized by a 48.3% revenue decline and a -$26.0M net loss in Q2, appears to be the inflection point where the divestment of Dutch operations and the shift to a capital-light model fundamentally altered Aegon's financial profile.

The dramatic revenue contraction in 2024 is consistent with the deconsolidation of the Dutch insurance business, which would remove a large volume of premiums from the top line. The subsequent net loss in Q2 2024 likely reflects transaction costs, write-downs, or accounting adjustments associated with this major restructuring. This period represents the clearest break from Aegon's historical profile as a traditional, balance-sheet-heavy insurer, setting the stage for its new identity as a more fee-based platform manager.

Reported Earnings May Mask Underlying Weakness

The strong 2026Q2 net income of $626.2M could be overstated if it is partially supported by favorable reserve releases or non-recurring items, as the historical data shows a pattern of volatile and often negative earnings that questions the durability of the current profitability.

The most significant analytical challenge is the inconsistency of Aegon's earnings stream. The company has swung from large losses (e.g., -$884.0M in 2022Q4) to profits within short periods, which is atypical for a well-run insurer and suggests earnings quality may be low. The 2026Q2 result, while positive, follows a quarter (2025Q4) with a much lower net income of $389.1M despite higher revenue, indicating that profitability is not scaling predictably with the top line. This pattern warrants skepticism about the sustainability of the current earnings level.

AEG — Frequently Asked Questions

Quick answers to the most common questions about buying AEG stock.

What was Aegon Ltd.'s (AEG) revenue in 2025?

For fiscal year 2025, Aegon Ltd. (AEG) reported total revenue of $26.86B. This represents a 135.0% increase compared to $11.43B in 1996.

Is Aegon Ltd. (AEG) profitable?

Aegon Ltd. (AEG) is profitable, generating $977.0M in net income for the fiscal year ending 2025 with a net profit margin of 3.6%.

What is Aegon Ltd.'s operating profit margin?

Aegon Ltd. (AEG) reported an operating income of $4.33B, resulting in an operating profit margin of 16.1%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Aegon Ltd.'s gross profit and gross margin?

Aegon Ltd. (AEG) generated $5.67B in gross profit for the year, representing a gross profit margin of 21.1%. This demonstrates the company's core pricing power and production efficiency.